0001062993-23-013634.txt : 20230615 0001062993-23-013634.hdr.sgml : 20230615 20230615161150 ACCESSION NUMBER: 0001062993-23-013634 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Banks Jerel A. CENTRAL INDEX KEY: 0001808930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 231017451 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-06-13 0001808898 Benitec Biopharma Inc. BNTC 0001808930 Banks Jerel A. C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 1 0 0 Chief Executive Officer 0 Options (right to buy) 0.23 2023-06-13 4 A 0 356900 0 A 2033-06-13 Common Stock 356900 356900 D The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026. /s/ Jerel A. Banks 2023-06-15